相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults
Neil French et al.
MALAWI MEDICAL JOURNAL (2016)
The burden of invasive pneumococcal disease in children with underlying risk factors in North America and Europe
M. A. Rose et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2014)
Immunogenicity, Impact on Carriage and Reactogenicity of 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine in Kenyan Children Aged 1-4 Years: A Randomized Controlled Trial
Laura L. Hammitt et al.
PLOS ONE (2014)
European enhanced surveillance of invasive pneumococcal disease in 2010: Data from 26 European countries in the post-heptavalent conjugate vaccine era
Adoracion Navarro Torne et al.
VACCINE (2014)
The Impact of 7-valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease: A Literature Review
Tin Tin Htar Myint et al.
ADVANCES IN THERAPY (2013)
Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial
Arto A. Palmu et al.
LANCET (2013)
Risk factors for community-acquired pneumonia in adults in Europe: a literature review
Antoni Torres et al.
THORAX (2013)
Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older
Lisa A. Jackson et al.
VACCINE (2013)
Have changing pneumococcal vaccination programmes impacted disease in Ontario?
Gillian H. Lim et al.
VACCINE (2013)
Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: Review of evidence on indirect effects
Stephanie M. Davis et al.
VACCINE (2013)
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
Lisa A. Jackson et al.
VACCINE (2013)
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults
Lisa A. Jackson et al.
VACCINE (2013)
Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway
Anneke Steens et al.
VACCINE (2013)
Cost-effectiveness of new adult pneumococcal vaccination strategies in Italy
Sara Boccalini et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Vaccines for preventing pneumococcal infection in adults
Sarah Moberley et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Effect of 10-Valent Pneumococcal Vaccine on Pneumonia among Children, Brazil
Eliane Terezinha Afonso et al.
EMERGING INFECTIOUS DISEASES (2013)
The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England
Albert Jan van Hoek et al.
JOURNAL OF INFECTION (2012)
Hyporesponsiveness Following Booster Immunization With Bacterial Polysaccharides Is Caused by Apoptosis of Memory B Cells
Siggeir F. Brynjolfsson et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Clinical and economic burden of community-acquired pneumonia among adults in Europe
T. Welte et al.
THORAX (2012)
Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany
Alexander Kuhlmann et al.
HEALTH ECONOMICS REVIEW (2012)
Primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in infants in Mali and Nigeria: a randomized controlled trial
Alassane Dicko et al.
BMC PUBLIC HEALTH (2011)
Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy
Geraldine Blanchard-Rohner et al.
EXPERT REVIEW OF VACCINES (2011)
Immunogenicity, reactogenicity and safety of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Mexican infants
Guillermo M. Ruiz-Palacios et al.
HUMAN VACCINES (2011)
Alterations in Marginal Zone Macrophages and Marginal Zone B Cells in Old Mice
Shirin Z. Birjandi et al.
JOURNAL OF IMMUNOLOGY (2011)
Suppressive Effect of Bacterial Polysaccharides on BAFF System Is Responsible for Their Poor Immunogenicity
Sunita Kanswal et al.
JOURNAL OF IMMUNOLOGY (2011)
A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design
Fikri Y. Avci et al.
NATURE MEDICINE (2011)
Immunogenicity, Safety, and Reactogenicity of the 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine and DTPa-IPV-Hib When Coadministered as a 3-dose Primary Vaccination Schedule in the Netherlands A Randomized Controlled Trial
Menno R. van den Bergh et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
The burden of hospitalisations for community-acquired pneumonia (CAP) and pneumococcal pneumonia in adults in Spain (2003-2007)
Ruth Gil-Prieto et al.
VACCINE (2011)
IL-21 induces death of marginal zone B cells during chronic inflammation
Luigi Tortola et al.
BLOOD (2010)
Significant decline in pneumonia admission rate after the introduction of routine 2+1 dose schedule heptavalent pneumococcal conjugate vaccine (PCV7) in children under 5 years of age in Kielce, Poland
M. Patrzalek et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2010)
Advances in pneumococcal vaccines: the 13-valent pneumococcal conjugate vaccine received market authorization in Europe
Ralf R. Reinert et al.
EXPERT REVIEW OF VACCINES (2010)
Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines
Daniel J. Isaacman et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
The Spectrum of Invasive Pneumococcal Disease at an Adult Tertiary Care Hospital in the Early 21st Century
Adriana M. Rueda et al.
MEDICINE (2010)
A Trial of a 7-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults.
Neil French et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Vaccinations in patients with immune-mediated inflammatory diseases
Jean-Francois Rahier et al.
RHEUMATOLOGY (2010)
Recommended Adult Immunization Schedule: United States, 2009 Advisory Committee on Immunization Practices
Dale L. Morse et al.
ANNALS OF INTERNAL MEDICINE (2009)
The thymus-independent immunity conferred by a pneumococcal polysaccharide is mediated by long-lived plasma cells
Morgan Taillardet et al.
BLOOD (2009)
Invasive Streptococcus pneumoniae infections in children and older adults in the north of Spain before and after the introduction of the heptavalent pneumococcal conjugate vaccine
E. Perez-Trallero et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2009)
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates
Katherine L. O'Brien et al.
LANCET (2009)
The 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Coadministered With DTPw-HBV/Hib and Poliovirus Vaccines: Assessment of Immunogenicity
Nancy Bermal et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the Licensed 7vCRM Vaccine
Timo Vesikari et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Invasive pneumococcal disease in the Netherlands: Syndromes, outcome and potential vaccine benefits
Angelique G. S. C. Jansen et al.
VACCINE (2009)
Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany
Simon Rueckinger et al.
VACCINE (2009)
Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines
Andrew J. Pollard et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Impact of heptavalent pneumococcal conjugate vaccine on nasopharyngeal carriage of penicillin-resistant Streptococcus pneumonide among day-care center attendees in central Greece
Ioanna N. Grivea et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2008)
Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004
Fangjun Zhou et al.
PEDIATRICS (2008)
Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway
Didrik F. Vestrheim et al.
VACCINE (2008)
Decline in pneumococcal meningitis after the introduction of the heptavalent-pneumococcal conjugate vaccine in northern France
F. Dubos et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2007)
Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial
Katherine L. O'Brien et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Effectiveness of the 7-valent pneumococcal conjugate vaccine: A population-based case-control study
Aurelio Barricarte et al.
CLINICAL INFECTIOUS DISEASES (2007)
Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis
Carlos G. Grijalva et al.
LANCET (2007)
Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine
Katherine A. Poehling et al.
PEDIATRICS (2007)
Streptococcus pneumoniae serotypes involved in children with pleural empyemas in France
H. Bekri et al.
ARCHIVES DE PEDIATRIE (2007)
Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine
KA Poehling et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae
MH Kyaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
T-independent type II immune responses generate memory B cells
TV Obukhanych et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Age-dependent development of the splenic marginal zone in human infants is associated with different causes of death
C Kruschinski et al.
HUMAN PATHOLOGY (2004)
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine
CG Whitney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen
S Kruetzmann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Low-level hypermutation in T cell-independent germinal centers compared with high mutation rates associated with T cell-dependent germinal centers
KM Toellner et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Marginal zone and B1B cells unite in the early response against T-independent blood-borne particulate antigens
F Martin et al.
IMMUNITY (2001)
23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial
N French et al.
LANCET (2000)
Cigarette smoking and invasive pneumococcal disease.
JP Nuorti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
